- Parliamentary Business
- Senators & Members
- News & Events
- About Parliament
- Visit Parliament
Table Of ContentsDownload PDF
Previous Fragment Next Fragment
29 November 2012
* 1317 MS GAMBARO: To ask the Minister for Immigration and Citizenship—In respect of Unaccompanied Humanitarian Minors (UHMs) who have obtained a protection visa, (a) how many arrange their own carer to avoid relocation to a different state, (b) how many reports has the department received, and/or is aware of, where UHMs have sourced new carers through Facebook and other social networking sites, and (c) how many of these UHMs are still in contact with, or monitored by, the department.
* 1318 MS GAMBARO: To ask the Minister for Immigration and Citizenship—In respect of Unaccompanied Humanitarian Minors (UHMs) turning 18 years of age, (a) what targeted support/transitional care arrangements are available, (b) what guidelines does the department issue to service providers to support UHMs in transition, (c) what analysis and assessments has the department undertaken to determine levels of homelessness amongst this group, and (d) by way of monthly breakdown, in (i) 2007-08, (ii) 2008-09, (iii) 2009-10, (iv) 2010-11, (v) 2011-12, and (vi) 2012-13 (to date), would the Minister provide the details on the levels of homelessness amongst this group.
* 1319 MS GAMBARO: To ask the Minister for Immigration and Citizenship—What transitional care arrangements are in place for Unaccompanied Humanitarian Minors exiting community detention.
* 1320 MS GAMBARO: To ask the Minister for Immigration and Citizenship—In respect of the the budgetary allocation for the department’s Community Programs and Children’s Division for 2012-13, (a) what is the total sum of the budgetary allocation, (b) what is the breakdown of allocation between community detention and Unaccompanied Humanitarian Minors.
* 1321 MS GAMBARO: To ask the Minister for Immigration and Citizenship—Are there processes utilised by the department in determining discrepancies in relation to the age of young people arriving in Australia from refugee backgrounds; and if so, what are the processes.
* 1322 MS GAMBARO: To ask the Minister for Immigration and Citizenship—Is the department aware of the concerns of service providers that there are inadequacies in the department’s age assessment processes; and if so, how are these inadequacies affecting (a) care and support arrangements, (b) physical and mental health assessments, (c) appropriate education or training support, and (d) access to youth services.
* 1323 MS GAMBARO: To ask the Minister for Immigration and Citizenship—In respect of the Refugee Youth Support Pilot, (a) what was the total cost, (b) what were the outcomes, and (c) is there any committed funding to allow for the further rollout of the pilot; and if not, what will happen to the 100 Unaccompanied Humanitarian Minors who were part of the pilot.
* 1324 MS GAMBARO: To ask the Minister for Immigration and Citizenship—In respect of the evaluation of the Refugee Support Pilot, (a) when will the evaluation be completed, (b) what are the assessment criteria for the evaluation, (c) is it being compared to other service providers, including the Life Without Barriers model, and (d) who is undertaking the evaluation.
* 1325 MS GAMBARO: To ask the Minister for Immigration and Citizenship—Would the Government consider releasing to market the tender (previously published on the AusTender website as ‘Accommodation, Care, Welfare and other services for unaccompanied humanitarian minors. APP DIAC 12/54. Category 8313159 - Refugee Program ) for the support of Unaccompanied Humanitarian Minors in community detention and under humanitarian visas; and if so, when.
* 1326 MR BRIGGS: To ask the Minister representing the Minister for Human Services—In respect of Employment Services Assessments, in 2011-12, (a) how many assessments did the department undertake, (b) what was the total cost to the department for delivering the assessments, and (c) how many qualified health professionals does the department employ to undertake the assessments.
* 1327 MR DUTTON: To ask the Minister for Health—In respect of the Medical Services Advisory Committee’s (MSAC) decision to not support an Australian Rheumatology Association (ARA) application for new joint injection items for consultant physicians, would the Minister provide, (a) the Medicare Benefit Schedule (MBS) item numbers considered by MSAC to determine, (i) patient access was not affected by the decision to remove the original rebates and the time period covered, and (ii) that the withdrawal of the original rebates had had no impact on referrals to radiologists for joint injection services and the time period covered, (b) the number of claims by each medical speciality, including general practitioners, rheumatologists and radiologists, for each of the item numbers for each year considered by MSAC in their assessment, (c) the number of referrals per annum to radiologists for joint injection services from rheumatologists, general practitioners and other specialists respectively for each year considered by MSAC in its assessment, and (d) the number of claims by medical specialty per annum for MBS item numbers 50124 and 50125 for the years (i) 2006-07, (ii) 2007-08, (iii) 2008-09, and (iv) 2009-10.
* 1328 MR ALEXANDER: To ask the Minister for Health—Since the Government’s announcement of a review of anticoagulation therapies in atrial fibrillation of 30 September 2011, (a) how many patients with atrial fibrillation have not been treated for stroke prevention, (b) how many strokes have occurred in patients with atrial fibrillation, (i) what is the estimated average health care costs for each stroke in these untreated patients, and (ii) what is the estimated cost to state and territories of strokes over this period, and (c) broken down by financial years to date, what has been the total cost incurred by Government for conducting the review.
* 1329 MR ALEXANDER: To ask the Minister for Health—In respect of new medicine to prevent stroke in atrial fibrillation patients, (a) is it a fact that new medicine has been reimbursed in New Zealand for over 12 months while Australian patients only have aspirin and warfarin available on the Pharmaceutical Benefits Scheme, and (b) can the Minister provide any other examples of medicines that have been reimbursed in New Zealand prior to being listed for reimbursement in Australia.
* 1330 MR ALEXANDER: To ask the Minister for Health—
(1) Would the Government consider listing new stroke prevention medicines on the Pharmaceutical Benefits Scheme (PBS) to help patients with atrial fibrillation, including those that are currently untreated and those who cannot tolerate warfarin.
(2) Would the Minister rule out conducting any more reviews, such as its Review of Anticoagulation Therapies in Atrial Fibrillation, for any new medicines recommended for listing on the PBS by the Pharmaceutical Benefits Advisory Committee.
* 1331 MRS MARKUS: To ask the Minister representing the Minister for Foreign Affairs—
(1) What steps will the G overnment take to assist Australian families of children abducted to previously non-Hague Convention states, prior to the ratification by these states of the Convention, where the terms of the Convention are not to be applied to historical abductions.
(2) In respect of Australian children abducted to Japan in international child custody disputes, (a) since 2009, how many Australian children have been abducted, and (b) what steps have been taken or processes initiated towards the development of a bilateral agreement with Japan.
B. C. WRIGHT
Clerk of the House of Representatives